Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.

Slattery ML, Wolff RK, Curtin K, Fitzpatrick F, Herrick J, Potter JD, Caan BJ, Samowitz WS.

Mutat Res. 2009 Jan 15;660(1-2):12-21. doi: 10.1016/j.mrfmmm.2008.10.001. Epub 2008 Oct 15.

2.

PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).

Slattery ML, Curtin K, Wolff R, Ma KN, Sweeney C, Murtaugh M, Potter JD, Levin TR, Samowitz W.

Cancer Causes Control. 2006 Apr;17(3):239-49.

PMID:
16489531
3.

Somatic alterations, metabolizing genes and smoking in rectal cancer.

Curtin K, Samowitz WS, Wolff RK, Herrick J, Caan BJ, Slattery ML.

Int J Cancer. 2009 Jul 1;125(1):158-64. doi: 10.1002/ijc.24338.

4.

Transcription factor 7-like 2 polymorphism and colon cancer.

Slattery ML, Folsom AR, Wolff R, Herrick J, Caan BJ, Potter JD.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):978-82. doi: 10.1158/1055-9965.EPI-07-2687.

5.

Tumor markers and rectal cancer: support for an inflammation-related pathway.

Slattery ML, Wolff RK, Herrick J, Caan BJ, Samowitz W.

Int J Cancer. 2009 Oct 1;125(7):1698-704. doi: 10.1002/ijc.24467.

6.

Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.

Slattery ML, Curtin K, Sweeney C, Levin TR, Potter J, Wolff RK, Albertsen H, Samowitz WS.

Int J Cancer. 2007 Feb 1;120(3):656-63.

7.

IL6 genotypes and colon and rectal cancer.

Slattery ML, Wolff RK, Herrick JS, Caan BJ, Potter JD.

Cancer Causes Control. 2007 Dec;18(10):1095-105. Epub 2007 Aug 13.

8.

A comparison of colon and rectal somatic DNA alterations.

Slattery ML, Curtin K, Wolff RK, Boucher KM, Sweeney C, Edwards S, Caan BJ, Samowitz W.

Dis Colon Rectum. 2009 Jul;52(7):1304-11. doi: 10.1007/DCR.0b013e3181a0e5df.

9.

GSTM-1 and NAT2 and genetic alterations in colon tumors.

Slattery ML, Curtin K, Ma K, Schaffer D, Potter J, Samowitz W.

Cancer Causes Control. 2002 Aug;13(6):527-34.

PMID:
12195642
10.

IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53.

Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS, Ogino S.

Neoplasia. 2007 Dec;9(12):1091-8.

11.

Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors.

Slattery ML, Wolff RK, Herrick JS, Caan BJ, Samowitz W.

Nutr Cancer. 2010;62(4):436-42. doi: 10.1080/01635580903441204.

12.

APC mutations and other genetic and epigenetic changes in colon cancer.

Samowitz WS, Slattery ML, Sweeney C, Herrick J, Wolff RK, Albertsen H.

Mol Cancer Res. 2007 Feb;5(2):165-70. Epub 2007 Feb 9.

13.

The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer.

Samowitz WS, Curtin K, Wolff RK, Albertsen H, Sweeney C, Caan BJ, Ulrich CM, Potter JD, Slattery ML.

Genes Chromosomes Cancer. 2008 Oct;47(10):835-44. doi: 10.1002/gcc.20584.

14.

Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer.

Curtin K, Samowitz WS, Wolff RK, Ulrich CM, Caan BJ, Potter JD, Slattery ML.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3384-8. doi: 10.1158/1055-9965.EPI-09-0955.

15.

Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet.

Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, Wolff RK, Albertsen H, Potter JD, Samowitz WS.

Carcinogenesis. 2007 Aug;28(8):1672-9. Epub 2007 Apr 21.

16.

MTHFR variants reduce the risk of G:C->A:T transition mutations within the p53 tumor suppressor gene in colon tumors.

Ulrich CM, Curtin K, Samowitz W, Bigler J, Potter JD, Caan B, Slattery ML.

J Nutr. 2005 Oct;135(10):2462-7.

17.

TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.

Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS.

Hum Pathol. 2007 Apr;38(4):614-20. Epub 2007 Jan 31.

PMID:
17270239
18.

The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.

Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, Niedzwiecki D, Compton C, Mayer RJ, Goldberg R, Bertagnolli MM, Boland CR.

Gastroenterology. 2007 Jan;132(1):127-38. Epub 2006 Sep 20.

PMID:
17087942
19.

Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.

Ogino S, Kawasaki T, Kirkner GJ, Ogawa A, Dorfman I, Loda M, Fuchs CS.

J Pathol. 2006 Oct;210(2):147-54.

PMID:
16850502
20.

Gene expression in colon cancer: A focus on tumor site and molecular phenotype.

Slattery ML, Pellatt DF, Mullany LE, Wolff RK, Herrick JS.

Genes Chromosomes Cancer. 2015 Sep;54(9):527-41. doi: 10.1002/gcc.22265. Epub 2015 Jul 14.

PMID:
26171582

Supplemental Content

Support Center